Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy.
about
Biomarkers, diagnosis and management of sepsis-induced acute kidney injury: a narrative reviewCurrent and Future Considerations for the Treatment of Hospital-Acquired PneumoniaMicrobiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unitPolymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.A 2015 Update on Ventilator-Associated Pneumonia: New Insights on Its Prevention, Diagnosis, and Treatment.The Relationship of Paranasal Sinus Opacification to Hospital-Acquired Pneumonia in the Neurologic Intensive Care Unit Patient.Investigational drugs in phase I and phase II clincial trials for the treatment of hospital-acquired pneumonia.Challenges and opportunities in the treatment of ventilator-associated pneumonia.Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.[Ventilation as a trigger for organ dysfunction and sepsis].Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.A comparison of virulence patterns and in vivo fitness between hospital- and community-acquired methicillin-resistant Staphylococcus aureus related to the USA400 clone.Prevalence of respiratory colonisations and related antibiotic resistances among paediatric tracheostomised patients of a long-term rehabilitation centre in Italy.Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function.Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.Feasibility of Antimicrobial Stewardship (AMS) in Critical Care Settings: A Multidisciplinary Approach Strategy.
P2860
Q26825317-43E77A42-65E3-49D2-820A-9BB68C8DE767Q28071882-4B0D1E7B-70BA-4D9D-A78F-A5E3819347BEQ34075262-D58DBB0F-5743-4159-AD45-BCC4EBCCB988Q36257537-3030E512-FE33-474A-906C-FC26BDCA3A3EQ38538710-18E03475-7B8F-4216-B4C9-2CF158AE5DBBQ38694803-83051036-CAB2-40EB-B6B7-EC6C2EE1B87AQ38783043-E48D521B-DDDD-4DCB-BCB8-693441BCBE4FQ38988630-8C9E701A-1EE7-46A3-B0F4-EA5533E29A9CQ39153521-817B2B24-F3D7-4A84-BFF3-371F37AF3849Q41234247-9E8D0A33-76C2-4798-BD23-A306F28FC571Q41695620-9F962DF3-20A4-4858-9786-3D737259CF51Q41703074-AF634698-990D-4847-82FF-DD9858C5745BQ45902569-F6B45F86-119C-46EC-B18B-7CE3A948D75EQ50089280-C09B7139-3BC1-4623-99C0-91D78071E2E8Q51739440-132839F2-645D-43EA-B9E1-2FF689374C73Q55410845-991BF309-A867-4B86-8CCF-DB9B2FB89891
P2860
Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Update on management options i ...... d economic aspects of therapy.
@en
type
label
Update on management options i ...... d economic aspects of therapy.
@en
prefLabel
Update on management options i ...... d economic aspects of therapy.
@en
P2860
P356
P1476
Update on management options i ...... d economic aspects of therapy.
@en
P2093
Michael Wilke
Rolf Grube
P2860
P356
10.2147/IDR.S25985
P407
P577
2013-12-18T00:00:00Z